Patents by Inventor Xiangru Lu

Xiangru Lu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANNEXIN A5 COMPOSITIONS AND METHODS
    Publication number: 20230374091
    Abstract: Described herein in aspects is annexin A5 for interacting with angiotensin converting enzyme 2 (ACE2) and/or for preventing and/or treating a coronavirus infection. Also described is a method for preventing and/or treating an ACE2-mediated infection and/or a coronavirus infection, the method comprising administering annexin A5 to a subject in need thereof.
    Type: Application
    Filed: October 8, 2021
    Publication date: November 23, 2023
    Inventors: Qingping Feng, Xiangru Lu, Peter B. Stathopulos, Stephen Barr
  • EGFR antagonist for the treatment of heart disease
    Patent number: 9861694
    Abstract: The present invention relates to the use of epidermal growth factor receptor (EGFR) antagonists in methods and compositions useful for the treatment of heart disease in a subject. In one embodiment, the methods of the present invention comprise: (a) administering to the subject an EGFR antagonist; and (b) inhibiting or substantially inhibiting the EGFR signal transduction cascade. In another embodiment the method of the present invention may be used in combination with another heart disease therapy.
    Type: Grant
    Filed: December 3, 2014
    Date of Patent: January 9, 2018
    Inventors: Qingping Feng, Xiangru Lu
  • Annexin and its use to treat inflammatory disorders
    Patent number: 9192649
    Abstract: There is provided a composition comprising an effective amount of Annexin A5 for use in treatment of an inflammatory disorder. There is provided a composition comprising an effective amount of Annexin A5 for use in improving organ function. Methods for administering such compositions for treatment of animals are also provided.
    Type: Grant
    Filed: October 16, 2009
    Date of Patent: November 24, 2015
    Assignee: LONDON HEALTH SCIENCES CENTRE RESEARCH INC.
    Inventors: Qingping Feng, Xiangru Lu, Paul Arnold
  • EGFR ANTAGONIST FOR THE TREATMENT OF HEART DISEASE
    Publication number: 20150147386
    Abstract: The present invention relates to the use of epidermal growth factor receptor (EGFR) antagonists in methods and compositions useful for the treatment of heart disease in a subject. In one embodiment, the methods of the present invention comprise: (a) administering to the subject an EGFR antagonist; and (b) inhibiting or substantially inhibiting the EGFR signal transduction cascade. In another embodiment the method of the present invention may be used in combination with another heart disease therapy.
    Type: Application
    Filed: December 3, 2014
    Publication date: May 28, 2015
    Inventors: Qingping FENG, Xiangru LU
  • EGFR ANTAGONIST FOR THE TREATMENT OF HEART DISEASE
    Publication number: 20130230581
    Abstract: The present invention relates to the use of epidermal growth factor receptor (EGFR) antagonists in methods and compositions useful for the treatment of heart disease in a subject. In one embodiment, the methods of the present invention comprise: (a) administering to the subject an EGFR antagonist; and (b) inhibiting or substantially inhibiting the EGFR signal transduction cascade. In another embodiment the method of the present invention may be used in combination with another heart disease therapy.
    Type: Application
    Filed: November 30, 2011
    Publication date: September 5, 2013
    Inventors: Qingping Feng, Xiangru Lu
  • ANNEXIN AND ITS USE TO TREAT INFLAMMATORY DISORDERS
    Publication number: 20120014920
    Abstract: There is provided a composition comprising an effective amount of Annexin A5 for use in treatment of an inflammatory disorder. There is provided a composition comprising an effective amount of Annexin A5 for use in improving organ function. Methods for administering such compositions for treatment of animals are also provided.
    Type: Application
    Filed: October 16, 2009
    Publication date: January 19, 2012
    Applicant: LONDON HEALTH SCIENCES CENTRE RESEARCH INC.
    Inventors: Qingping Feng, Xiangru Lu, Paul Arnold